The Medicines Company to Announce Second-Quarter 2017 Financial Results on August 9

31 Jul 2017

The Medicines Company (NASDAQ:MDCO) will host a conference call on Wednesday, August 9, 2017, at 8:30 a.m., Eastern Daylight Time, to discuss its second-quarter 2017 financial results and operational developments.

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website. A replay of the webcast will be available on the website following the conference call.

The conference call may also be accessed by telephone as follows:

U.S./Canada:     (877) 359-9508
International: (224) 357-2393
Conference ID: 58233884
 

A taped replay of the conference call will be available following the call and may be accessed as follows:

U.S./Canada:     (855) 859-2056
International: (404) 537-3406
Conference ID: 58233884
 

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose — to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.


Contacts

The Medicines Company
Media
Meg Langan, 973-290-6319
Vice President
margaret.langan@themedco.com
or
Investor Relations
Krishna Gorti, M.D., 973-290-6122
Vice President, Investor Relations
krishna.gorti@themedco.com

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information

Human Resources
Verification of employment
Tel 973 290 6361
Fax 862 207 6361

Investors Relations

Krishna Gorti, MD
Tel 973 290 6122
krishna.gorti@themedco.com

Media Inquiries

Michael Blash
Tel 973 290 6100
michael.blash@themedco.com